Live feed17:20:10·432dINSIDERFilingvia QuantisnowChief Scientific Officer Kastelein Johannes Jacob Pieter was granted 19,302 units of Ordinary Shares and converted options into 45,481 units of Ordinary Shares, increasing direct ownership by 134% to 79,481 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.NAMS· NewAmsterdam Pharma Company N.V.Health CareOriginal source
